UniProt ID | WDR61_MOUSE | |
---|---|---|
UniProt AC | Q9ERF3 | |
Protein Name | WD repeat-containing protein 61 | |
Gene Name | Wdr61 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 305 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Component of the PAF1 complex (PAF1C) which has multiple functions during transcription by RNA polymerase II and is implicated in regulation of development and maintenance of embryonic stem cell pluripotency. PAF1C associates with RNA polymerase II through interaction with POLR2A CTD non-phosphorylated and 'Ser-2'- and 'Ser-5'-phosphorylated forms and is involved in transcriptional elongation, acting both indepentently and synergistically with TCEA1 and in cooperation with the DSIF complex and HTATSF1. PAF1C is required for transcription of Hox and Wnt target genes. PAF1C is involved in hematopoiesis and stimulates transcriptional activity of KMT2A/MLL1. PAF1C is involved in histone modifications such as ubiquitination of histone H2B and methylation on histone H3 'Lys-4' (H3K4me3). PAF1C recruits the RNF20/40 E3 ubiquitin-protein ligase complex and the E2 enzyme UBE2A or UBE2B to chromatin which mediate monoubiquitination of 'Lys-120' of histone H2B (H2BK120ub1); UB2A/B-mediated H2B ubiquitination is proposed to be coupled to transcription. PAF1C is involved in mRNA 3' end formation probably through association with cleavage and poly(A) factors. Required for mono- and trimethylation on histone H3 'Lys-4' (H3K4me3), dimethylation on histone H3 'Lys-79' (H3K4me3). Required for Hox gene transcription. Component of the SKI complex which is thought to be involved in exosome-mediated RNA decay and associates with transcriptionally active genes in a manner dependent on PAF1C (By similarity).. | |
Protein Sequence | MTNQYSILFKQEQAHDDAIWSVAWETNKKENIETVVTGSLDDLVKVWKWRDERLELQWSLEGHQLGVVSVDISHTLPIAASSSLDAHIRLWDLENGKQMKSIDAGPVDAWTLAFSPDSQYLATGTHMGKVNIFGVESGKKEYSLDTRGKFILSIAYSPDGKYLASGAIDGIINIFDIATGKLLHTLEGHAMPIRSLTFSPDSQLLVTASDDGYIKIYDVQHANLAGTLSGHASWVLNVAFCPDDTHFVSSSSDKSVKVWDVGTRTCIHTFFDHQDQVWGVKYNGNGSKIVSVGDDQEIHVYDCPI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MTNQYSIL -------CCCCEEEE | 7.77 | - | |
2 | Acetylation | ------MTNQYSILF ------CCCCEEEEE | 30.91 | - | |
29 | Ubiquitination | VAWETNKKENIETVV EEEECCCCCCEEEEE | 59.05 | - | |
97 | Ubiquitination | LWDLENGKQMKSIDA EEECCCCEECCCCCC | 59.82 | - | |
139 | Ubiquitination | IFGVESGKKEYSLDT EEEECCCCEEEEECC | 52.27 | - | |
140 | Ubiquitination | FGVESGKKEYSLDTR EEECCCCEEEEECCC | 66.46 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WDR61_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WDR61_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WDR61_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TCPZ_HUMAN | CCT6A | physical | 26496610 | |
NMT1_HUMAN | NMT1 | physical | 26496610 | |
PFD1_HUMAN | PFDN1 | physical | 26496610 | |
PFD2_HUMAN | PFDN2 | physical | 26496610 | |
PP1RA_HUMAN | PPP1R10 | physical | 26496610 | |
TCPA_HUMAN | TCP1 | physical | 26496610 | |
TCPG_HUMAN | CCT3 | physical | 26496610 | |
NCOA4_HUMAN | NCOA4 | physical | 26496610 | |
TTC37_HUMAN | TTC37 | physical | 26496610 | |
PFD6_HUMAN | PFDN6 | physical | 26496610 | |
TCPH_HUMAN | CCT7 | physical | 26496610 | |
TCPD_HUMAN | CCT4 | physical | 26496610 | |
TCPB_HUMAN | CCT2 | physical | 26496610 | |
TCPQ_HUMAN | CCT8 | physical | 26496610 | |
TCPE_HUMAN | CCT5 | physical | 26496610 | |
NIN_HUMAN | NIN | physical | 26496610 | |
PAF1_HUMAN | PAF1 | physical | 26496610 | |
CDC73_HUMAN | CDC73 | physical | 26496610 | |
TPC13_HUMAN | TRAPPC13 | physical | 26496610 | |
LEO1_HUMAN | LEO1 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...